Research case studies Explore a selection of reports that spotlight particular areas of research at the Crick over the past five years.
Postdoctoral clinical fellows Opportunities for postdoctoral clinicians to consolidate their research experience.
Breadcrumb Robert J Wilkinson Wilkinson lab Tuberculosis Laboratory : Publications Lab contentLab contentIn this section Overview Areas of interest Publications Members Vacancies News Khayelitsha, South Africa: a peri-urban township of around 400000 people 30 km from the centre of Cape Town. In Khayelitsha the chances of developing tuberculosis in any year are around 1%, much higher if a person is HIV-coinfected. Toggle to view hero caption PublicationsYear published2023 (1)2021 (1)2020 (2)2016 (1) Facet Year publishedResearch topicsHuman Biology & Physiology (5)Immunology (5)Infectious Disease (5)Model Organisms (5)Genetics & Genomics (1)Imaging (1) Facet Research topicsPublication typeJournal article (5)Primary research (5) Facet Publication typeJournal (-)Antimicrobial Agents and Chemotherapy (5) Facet Journal Publications Displaying 1 - 5 of 5Last updated : 19 April 2024 03:45 A preclinical model of TB meningitis to determine drug penetration and activity at the sites of disease Authors (12) Faye Lanni Rosleine Antilus Sainte Mark Hansen Jr. Paul Parigi Firat Kaya Katherine LoMauro[...]Robert Wilkinson Sean Wasserman Brendan K Podell Martin Gengenbacher Véronique Dartois Antimicrobial Agents and Chemotherapy Published 1 December 2023 Crick labs/ facilitiesRobert J WilkinsonIn Vivo ImagingBiological Research FacilityFull details Plasma pharmacokinetics of high dose oral versus intravenous rifampicin in patients with tuberculous meningitis: a randomized controlled trial Authors (21) Sean Wasserman Angharad Davis Cari Stek Maxwell Chirehwa Stephani Botha Remy Daroowala[...] Lubbe Wiesner John Black Graeme Meintjes Gary MaartensRobert Wilkinson Antimicrobial Agents and Chemotherapy Published 1 August 2021 Crick labsRobert J WilkinsonFull details Natural polymorphisms in Mycobacterium tuberculosis conferring resistance to delamanid in drug-naive patients Authors (17) Martina L Reichmuth Rico Hömke Kathrin Zürcher Peter Sander Anchalee Avihingsanon Jimena Collantes[...] Erik C Böttger Sebastien Gagneux Matthias Egger Peter M Keller International epidemiology Databases to Evaluate AIDS (IeDEA) Antimicrobial Agents and Chemotherapy Published 1 November 2020 Crick labsRobert J WilkinsonFull details HIV coinfection is associated with low-fitness rpoB variants in rifampicin-resistant Mycobacterium tuberculosis Authors (21) Chloé Loiseau Daniela Brites Miriam Reinhard Kathrin Zürcher Sonia Borrell Marie Ballif[...] Nicola Zetola Basra Doulla Erik C Böttger Matthias Egger Sebastien Gagneux Antimicrobial Agents and Chemotherapy Published 21 September 2020 Crick labsRobert J WilkinsonFull details HIV-1 coinfection does not reduce exposure to rifampicin, isoniazid, and pyrazinamide in South African tuberculosis outpatients Authors (7) Neesha Rockwood Graeme Meintjes Maxwell Chirehwa Lubbe Wiesner Helen McIlleronRobert Wilkinson Paolo Denti Antimicrobial Agents and Chemotherapy Published 1 October 2016 Crick labsRobert J WilkinsonFull details Share the page Share on Twitter Share on Facebook Share on LinkedIn Share on Email
A preclinical model of TB meningitis to determine drug penetration and activity at the sites of disease Authors (12) Faye Lanni Rosleine Antilus Sainte Mark Hansen Jr. Paul Parigi Firat Kaya Katherine LoMauro[...]Robert Wilkinson Sean Wasserman Brendan K Podell Martin Gengenbacher Véronique Dartois Antimicrobial Agents and Chemotherapy Published 1 December 2023 Crick labs/ facilitiesRobert J WilkinsonIn Vivo ImagingBiological Research FacilityFull details
Plasma pharmacokinetics of high dose oral versus intravenous rifampicin in patients with tuberculous meningitis: a randomized controlled trial Authors (21) Sean Wasserman Angharad Davis Cari Stek Maxwell Chirehwa Stephani Botha Remy Daroowala[...] Lubbe Wiesner John Black Graeme Meintjes Gary MaartensRobert Wilkinson Antimicrobial Agents and Chemotherapy Published 1 August 2021 Crick labsRobert J WilkinsonFull details
Natural polymorphisms in Mycobacterium tuberculosis conferring resistance to delamanid in drug-naive patients Authors (17) Martina L Reichmuth Rico Hömke Kathrin Zürcher Peter Sander Anchalee Avihingsanon Jimena Collantes[...] Erik C Böttger Sebastien Gagneux Matthias Egger Peter M Keller International epidemiology Databases to Evaluate AIDS (IeDEA) Antimicrobial Agents and Chemotherapy Published 1 November 2020 Crick labsRobert J WilkinsonFull details
HIV coinfection is associated with low-fitness rpoB variants in rifampicin-resistant Mycobacterium tuberculosis Authors (21) Chloé Loiseau Daniela Brites Miriam Reinhard Kathrin Zürcher Sonia Borrell Marie Ballif[...] Nicola Zetola Basra Doulla Erik C Böttger Matthias Egger Sebastien Gagneux Antimicrobial Agents and Chemotherapy Published 21 September 2020 Crick labsRobert J WilkinsonFull details
HIV-1 coinfection does not reduce exposure to rifampicin, isoniazid, and pyrazinamide in South African tuberculosis outpatients Authors (7) Neesha Rockwood Graeme Meintjes Maxwell Chirehwa Lubbe Wiesner Helen McIlleronRobert Wilkinson Paolo Denti Antimicrobial Agents and Chemotherapy Published 1 October 2016 Crick labsRobert J WilkinsonFull details